Proteomics: A new dimension to decode small cell lung cancer.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 38181738.
- Also identified by DOI 10.1016/j.cell.2023.11.042 and PMC identifier 11161206.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Small cell lung cancer (SCLC) is a recalcitrant malignancy. Conquering it will require deep insight into its biology. In this issue of Cell, Liu and colleagues describe proteomic and phosphoproteomic landscapes of resected SCLC tumors and illustrate the potential of this knowledge to identify new SCLC vulnerabilities.
Medical subject headings
- Small Cell Lung Carcinoma
- Lung Neoplasms